Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
The Journal of Pharmacy and Pharmacology|May 24, 2001
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitorJ M Dogné, J Wouters, S Rolin, et al.Arzneimittel-Forschung|January 1, 1985
Pharmacological properties of the new potent diuretic torasemide in rats and dogsA Ghys, J Denef, J M de Suray, et al.Biochemical Pharmacology|April 20, 1994
A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channelsB Pirotte, M H Antoine, P de Tullio, et al.Experientia|September 15, 1994
Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic isletsM H Antoine, B Pirotte, M Hermann, et al.Journal De Pharmacie De Belgique|June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemideJ M Dogné, P Neven, J Damas, et al.European Journal of Pharmacology|August 22, 1996
Dibenzoazepine analogues: the electrophysiological properties of JL3, a potential atypical antidepressantJ F Liégeois, J Scuvée-Moreau, I Giesbers, et al.Current Medicinal Chemistry|July 27, 2000
Recent advances in inducible cyclooxygenase (COX-2) inhibitionX de Leval, J Delarge, F Somers, et al.Journal De Pharmacie De Belgique|August 4, 1999
Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative studyX de Leval, J M Dogné, P Neven, et al.Biochemical and Biophysical Research Communications|September 23, 1997
JL 13, a potential successor to clozapine, is less sensitive to oxidative phenomenaJ F Liégeois, A Mouithys-Mickalad, J Bruhwyler, et al.The Journal of Pharmacy and Pharmacology|May 1, 1993
Evaluation of the inhibitory activity on serine and aspartic proteases of 4-amino-4H-1,2,4-triazole and 5-aminothiazole derivatives structurally related to beta-lactam antibioticsA C Vilain, B Pirotte, I Vergely, et al.Pageof 7